Armata Pharmaceuticals Announces Two U.S. Patents Covering AP-SA02 And AP-PA02 Phage Therapies, With Protection Until At Least 2041
Share
Why It Matters
Armata got patents on two new medicines made from special viruses. This protects their work from competitors until at least 2041.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.